Search research articles
Contact Us
Filters
Showing results (1-10 of 28) with videos related to
Page
of 3
Sort By:
Current Drug Targets
|
June 16, 2015
Structural and Functional Aspects of Extended-Spectrum AmpC Cephalosporinases
Rachel A Powers
Journal of Medicinal Chemistry
|
July 12, 2002
Structure-based approach for binding site identification on AmpC beta-lactamase
Rachel A Powers, Brian K Shoichet
Structure (London, England : 1993)
|
July 18, 2002
Structure-based discovery of a novel, noncovalent inhibitor of AmpC beta-lactamase
Rachel A Powers, Federica Morandi, Brian K Shoichet
Accounts of Chemical Research
|
August 2, 2013
Class D β-lactamases: a reappraisal after five decades
David A Leonard, Robert A Bonomo, Rachel A Powers
Microbiology Spectrum
|
July 10, 2026
Environmental species from theTelluria group as the putative origin of bifunctionalβ-lactamases
Pedro Penzotti, Gabriel Gutkind, Rachel A Powers, et al.
Acta Crystallographica. Section D, Biological Crystallography
|
September 6, 2012
Structural analysis of the Asn152Gly mutant of P99 cephalosporinase
James F Ruble, Scott T Lefurgy, Virginia W Cornish, et al.
Bioorganic & Medicinal Chemistry
|
May 20, 2014
Structure-based efforts to optimize a non-β-lactam inhibitor of AmpC β-lactamase
Jenna M Hendershot, Uma J Mishra, Robert P Smart, et al.
Protein Science : a Publication of the Protein Society
|
December 21, 2016
Exploring the potential of boronic acids as inhibitors of OXA-24/40 β-lactamase
Josephine P Werner, Joshua M Mitchell, Magdalena A Taracila, et al.
Biochemistry
|
November 19, 2009
The 1.4 A crystal structure of the class D beta-lactamase OXA-1 complexed with doripenem
Kyle D Schneider, Mary E Karpen, Robert A Bonomo, et al.
Antimicrobial Agents and Chemotherapy
|
October 30, 2013
Structural origins of oxacillinase specificity in class D β-lactamases
Cynthia M June, Beth C Vallier, Robert A Bonomo, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 28) with videos related to
Sort By:
Page
of 3
Current Drug Targets
|
June 16, 2015
Structural and Functional Aspects of Extended-Spectrum AmpC Cephalosporinases
Rachel A Powers
Journal of Medicinal Chemistry
|
July 12, 2002
Structure-based approach for binding site identification on AmpC beta-lactamase
Rachel A Powers, Brian K Shoichet
Structure (London, England : 1993)
|
July 18, 2002
Structure-based discovery of a novel, noncovalent inhibitor of AmpC beta-lactamase
Rachel A Powers, Federica Morandi, Brian K Shoichet
Accounts of Chemical Research
|
August 2, 2013
Class D β-lactamases: a reappraisal after five decades
David A Leonard, Robert A Bonomo, Rachel A Powers
Microbiology Spectrum
|
July 10, 2026
Environmental species from theTelluria group as the putative origin of bifunctionalβ-lactamases
Pedro Penzotti, Gabriel Gutkind, Rachel A Powers, et al.
Acta Crystallographica. Section D, Biological Crystallography
|
September 6, 2012
Structural analysis of the Asn152Gly mutant of P99 cephalosporinase
James F Ruble, Scott T Lefurgy, Virginia W Cornish, et al.
Bioorganic & Medicinal Chemistry
|
May 20, 2014
Structure-based efforts to optimize a non-β-lactam inhibitor of AmpC β-lactamase
Jenna M Hendershot, Uma J Mishra, Robert P Smart, et al.
Protein Science : a Publication of the Protein Society
|
December 21, 2016
Exploring the potential of boronic acids as inhibitors of OXA-24/40 β-lactamase
Josephine P Werner, Joshua M Mitchell, Magdalena A Taracila, et al.
Biochemistry
|
November 19, 2009
The 1.4 A crystal structure of the class D beta-lactamase OXA-1 complexed with doripenem
Kyle D Schneider, Mary E Karpen, Robert A Bonomo, et al.
Antimicrobial Agents and Chemotherapy
|
October 30, 2013
Structural origins of oxacillinase specificity in class D β-lactamases
Cynthia M June, Beth C Vallier, Robert A Bonomo, et al.
Page
of 3